Last reviewed · How we verify

NCT04311268

Follow Fever to Decide

Completed NA Last updated 7 April 2022
What this trial tests

NA trial testing F2D armband in Body Temperature Changes in 306 participants. Completed in 18 December 2021.

Timeline
13 March 2020
Primary endpoint
18 December 2021
18 December 2021

Quick facts

Lead sponsorSlb Pharma
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment306
Start date13 March 2020
Primary completion18 December 2021
Estimated completion18 December 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Slb Pharma

Who can join

Adults 18 to 80, any sex, with Body Temperature Changes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Body temperature is one of the markers of biological rhythms. The precise determination of the functioning of the biological clock for an individual is essential to understanding his physiological state at a given time. This condition is dependent on the "timing" of its central clock on the time scale (chronotype). The provision of a simple-to-use (F2D cuff), non-invasive and time-dependable temperature tool and the creation of appropriate algorithms would allow access to the operation of the central clock and open up many therapeutic applications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Body Temperature Changes

Currently open trials in the same condition.

Other Slb Pharma trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04311268.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing